N. Achour

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

PANERB study: Panitumumab after cetuximab-based regimen failure.

J. Douillard, J. Raoul, J. Metges, 2010 .

Descriptive Study of Drug Induced Liver Injury in Kidney Transplant Patients

N. Achour, H. Fetati, A. Berradia, 2020 .

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.